Richard Durant is a journalist who writes for Seeking Alpha, focusing on providing analysis and insights on various stocks and companies. His articles cover a range of industries, including technology, energy, and manufacturing. Richard aims to provide readers with valuable information to help them make informed investment decisions.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Richard Durant’s articles primarily focus on investment analysis, with a significant emphasis on technology companies and the stock market. His coverage heavily revolves around providing insights into specific stocks and industries. As such, he would likely be interested in pitches that offer unique perspectives or data-driven analyses related to technology companies, especially those listed on major stock exchanges like NYSE.
Durant's interest in finance-related topics suggests that he may appreciate expert commentary from financial analysts or professionals within the tech industry who can provide valuable insights into market trends, company performance, and growth potential.
It is important to note that Richard has not specified a geographic focus but rather focuses on international markets when analyzing investments. Therefore, any pitches should consider this global perspective when offering relevant insights or analysis.
This information evolves through artificial intelligence and human feedback. Improve this profile .
ClearPoint Neuro reported strong YoY growth in Q3, but the stock reacted negatively. Check out my recommendation for CLPT stock.
Financial writer analyzes Cognex's growth drivers & struggles in core business, expects macro headwinds, but optimistic on long-term potential. Read more here.
By: Richard Durant
TransMedics' Q3 results were weak, but long-term growth opportunities remain. Learn why TMDX stock is a compelling buy despite short-term challenges.
Nov. 13, 2024 10:31 AM ET BrainsWay Ltd. (BWAY) Stock Richard Durant 8.04K Follower s Follow Play
By: Richard Durant
Read here for analysis of Planet Labs' Q2'25 results and future outlook, highlighting challenges in fundamentals and investor sentiment. Read more on PL stock here.
AST SpaceMobile's share price dropped after the release of its Q3 earnings results. Check out why I believe that ASTS stock is still reasonably valued.
By: Richard Durant
Spire Global’s maritime business sale strengthens its balance sheet. Read why SPIR stock offers value amidst market optimism.
By: Richard Durant
Analysis of Ginkgo Bioworks' Q3 results and business model, with a focus on growth, customer acquisition and cash flow generation. Read the DNA stock earnings analysis.
By: Richard Durant
Blade's growth was weak in Q3, largely due to the company abandoning activities with marginal economics.
By: Richard Durant
BlackSky's Q3 results were disappointing, but the stock has regained ground. Find out why BKSY stock needs greater scale to meet investor expectations.
(833) 317-6278 
